Provider Preference, Logistical Challenges, or Vaccine Hesitancy? Analyzing Parental Decision-Making in School Vaccination Programs: A Qualitative Study in Sydney, Australia by Leigh McIndoe, Alexandra Young, Cristyn Davies, Cassandra Vujovich-Dunn, Stephanie Kean, Michelle Dives, Vicky Sheppeard

Subjects: Get full text

Protective efficacy of classical vaccines and vaccination protocols against an exotic Newcastle disease virus genotype VII.2 in Belgian layer and broiler chickens by Mieke Steensels, Colas Soldan, Fabienne Rauw, Virginie Roupie, Bénédicte Lambrecht

Subjects: Get full text

COVID-19 vaccines as a game-changing tool? A corpus-based study of vaccine communication in People's Daily and The New York Times by Zhihan Wen, Ming Liu, Changpeng Huan

Subjects: Get full text

Vaccines in the fight against antimicrobial resistance – perspectives from South Africa by A Brink, A Kgasi, A Musyoki, B Kagina, C Feldman, D Reddy, E du Toit, E Kalanxhi, J Meyer, I Impalli, M Schönfeldt, M Sibanda, N Schellack, P Skosana, S Essack, S Dlamini, Y Ramsamy

Get full text

Bar Coding Vaccines - More Than a 'check-out' Issue by Monika Naus

Get full text

Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines by Syed Mohammed Basheeruddin Asdaq, Shahamah Jomah, Syed Imam Rabbani, Ali Musharraf Alamri, Salman Khalaf Salem Alshammari, Badr Sami Duwaidi, Majed Sadun Alshammari, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani, Nagaraja Sreeharsha, Mohd. Imran

“…Among them are BioNTech and Moderna vaccines (mRNA based); ChAdOx1, Gam-COVID-Vac, Janssen vaccines (vector-based); CoronaVac, COVAXIN (virus inactivated); and EpiVacCorona vaccine (viral peptide). …”
Get full text

Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines by Qian Zheng, Misi He, Zejia Mao, Yue Huang, Xiuying Li, Ling Long, Mingfang Guo, Dongling Zou

Subjects: “…therapeutic vaccines…”
Get full text

Efficacies of corynebacterium pseudotuberculosis vaccines against caseous lymphadenitis in mice and sheep by Osman Erganiş, H. Hüseyin Hadimli, Kürşat Kav, Aslı Sakmanoğlu, Zafer Sayın, Yasemin Pınarkara

Subjects: Get full text

Kenyans’ Perceptions of the Risks of COVID-19 Vaccines: A Scoping Review by Faith Anyango Ochieng’, Donal O'Mathuna

Subjects: Get full text

Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals by Pit Sze Liew, Mohd Hair-Bejo

“…Although there are no edible plant-produced animal vaccines in the market, plant-based vaccine technology has great potentials. …”
Get full text

A mathematical model studying mosquito-stage transmission-blocking vaccines by Ruijun Zhao, Jemal Mohammed-Awel

Subjects: Get full text

Neutralizing antibody responses to three XBB protein vaccines in older adults by Guo-Jian Yang, Mei Lu, Rui-Rui Chen, Shuang-Qing Wang, Sheng Wan, Xue-Dong Song, Guo-Ping Cao, Lei Lv, Xue-Juan He, Bing-Dong Zhan, Mai-Juan Ma

“…This study was therefore undertaken to investigate and compare neutralizing antibody responses to three XBB-containing protein-based vaccines (trivalent XBB.1.5 vaccine, bivalent Omicron XBB vaccine, and tetravalent XBB.1 vaccine) head-to-head in 90 individuals aged >65 years. …”
Get full text

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines by Luis E. Fernandez, Mariano R. Gabri, Marcelo D. Guthmann, Roberto E. Gomez, Silvia Gold, Leonardo Fainboim, Daniel E. Gomez, Daniel F. Alonso

“…The present paper examines the role of NGc-gangliosides in tumor biology as well as the available preclinical and clinical data on these vaccine products. A brief discussion on the relevance of prioritization of cancer antigens in vaccine development is also included.…”
Get full text

The effect of meningococcal vaccines on new generation of systemic inflammatory markers in children by Omer Okuyan, Neval Elgormus, Seyma Dumur, Ugurcan Sayili, Hafize Uzun

Subjects: “…meningococcal vaccine…”
Get full text

Regulated microbe vaccines: from concept to (pre-clinical) reduction to practice by Richard Voellmy, David C Bloom, Nuria Vilaboa

Subjects: Get full text

An Overview of Live Attenuated Recombinant Pseudorabies Viruses for Use as Novel Vaccines by Bo Dong, Dante S. Zarlenga, Xiaofeng Ren

“…In this paper, we review the current status of live attenuated recombinant PRVs and live PRV-based vector vaccines with potential for controlling viral infections in animals.…”
Get full text

Potential Usefulness of Streptococcus pneumoniae Extracellular Membrane Vesicles as Antibacterial Vaccines by Chi-Won Choi, Edmond Changkyun Park, Sung Ho Yun, Sang-Yeop Lee, Seung Il Kim, Gun-Hwa Kim

“…Bacterial EMVs have recently become the focus of attention because of their potential as highly effective vaccines that cause few side effects. Here, we isolated the EMVs of Streptococcus pneumoniae and examined their potential as new vaccine candidates. …”
Get full text

Optimal individual strategies for influenza vaccines with imperfect efficacy and durability of protection by Francesco Salvarani, Gabriel Turinici

Subjects: Get full text

Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study by Prashasti Agrawal, MD, Michael Offin, MD, Victoria Lai, MD, Michelle S. Ginsberg, MD, Prasad S. Adusumilli, MD, FACS, Valerie W. Rusch, MD, Jennifer L. Sauter, MD, Teresa Ho, BS, Phillip Wong, PhD, Marjorie G. Zauderer, MD

Subjects: Get full text

Assessing the impact of educational methods on influenza vaccine uptake and patient knowledge and attitudes: a randomised controlled trial by Pei Lin Hu, Eileen Yi Ling Koh, Jolene Shi Han Tay, Valerie Xin-Bei Chan, Shermin Shi Min Goh, Sinead Zhen Wang

Subjects: Get full text